Apex Capital Management’s Johnson & Johnson JNJ Stock Holding History

Apex Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$5M	Sell	46,190 -4,300	-9%	-$445K	0.11%	149
2015 Q4	$5.19M	Buy	50,490 +153	+0.3%	+$15.4K	0.12%	147
2015 Q3	$4.7M	Sell	50,337 -4,014	-7%	-$388K	0.11%	153
2015 Q2	$5.3M	Sell	54,351 -429	-0.8%	-$43K	0.11%	146
2015 Q1	$5.51M	Sell	54,780 -3,356	-6%	-$341K	0.13%	140
2014 Q4	$6.08M	Sell	58,136 -300	-0.5%	-$31.6K	0.16%	121
2014 Q3	$6.23M	Buy	58,436 +2,083	+4%	+$216K	0.19%	89
2014 Q2	$5.9M	Buy	+56,353	New	+$5.7M	0.18%	95

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Apex Capital Management's JNJ Position: Q1 2016 in Review

Apex Capital Management reduced its Johnson & Johnson (JNJ) stake by 8.5% in Q1 2016, selling an estimated $445K and leaving 46,190 shares worth $5M. The position accounts for 0.11% of the portfolio, ranked #149.

Apex Capital Management first reported a position in JNJ in Q2 2014 and has held it in 8 quarters since. The position peaked at $6.23M in Q3 2014. 2,204 funds tracked by Wall St. Rank hold JNJ as of Q1 2016.

Apex Capital Management held 46,190 shares of Johnson & Johnson worth $5M as of Q1 2016.
Apex Capital Management sold 4,300 Johnson & Johnson shares in Q1 2016, an estimated $445K.
Johnson & Johnson made up 0.11% of Apex Capital Management's portfolio in Q1 2016, its #149 holding.
Apex Capital Management first reported a position in Johnson & Johnson in Q2 2014 and has held it in 8 quarters since.
Apex Capital Management's Johnson & Johnson position peaked at $6.23M in Q3 2014.
2,204 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.